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Complex karyotype in one patient with small cell variant
of T-prolymphocytic leukemia. Analysis by G-banding and
comparative genomic hybridization
We report the genetic changes in a case of small cell vari-
ant of T-prolymphocytic leukemia. The use of comparative
genomic hybridization allowed the characterization of other-
wise hidden genetic abnormalities such as a high level ampli-
fication on 8q24, the chromosomal site of the c-MYC onco-
gene, gain on 15q and deletions of 11p and 13q.
The small cell variant of T-prolymphocytic leukemia (T-PLL) is
a rare disorder representing around 20% of cases.1 The case
described here showed the clinical and immunologic features
characteristic of T-PLL, including co-expression of CD4 and CD8,
a phenotype frequent in the small cell variant of T-PLL.1,2 While
T-PLL is morphologically heterogeneous, the disease is charac-
terized by recurrent chromosome abnormalities, chiefly inv(14)
or t(14;14)(q11;q32) and trisomy 8q, thus supporting the
hypothesis that all the morphologic T-PLL variants constitute a
unique entity.1-6
A 41-year old female was seen for evaluation of lymphocyto-
sis. Physical examination revealed splenomegaly and lym-
phadenopathy. Peripheral blood counts showed a white blood
count of 104×109/L with 91% small prolymphocytes, Hb 8.6 g/dL
and platelets 131×109/L. Bone marrow showed increased cellu-
larity with a marked infiltration by small lymphocytes. Immu-
nophenotyping in circulating lymphocytes demonstrated a CD3+,
CD7+, CD38+, CD4+, CD8+ phenotype. A diagnosis of T-PLL was
made (small cell variant), and the patient was treated with 3
cycles of CHOP (cyclophosphamide, doxorubicin, vincristine and
prednisolone) with no response, but progression. The patient did
not respond to fludarabine (1 cycle) and 2’-deoxycoformycin (2
injections), and died with widespread disease (organomegaly,
rising counts, pleural effusion) six months after diagnosis. Kary-
otype analysis at diagnosis failed. G-banding analysis post-treat-
ment showed a complex hypodiploid karyotype with breakpoints




The following chromosomal imbalances were identified using
comparative genomic hybridization (CGH): loss of chromosomal
material on 4q11-q24, 4q32-q35, 6q24-q27, 7q36, 11p11-p12
and 13q13-q34; and gains on 8q24, 14q11-q32 and 15q23-q26
(Figure 1). A high amplification on 8q24 was detected. 
Chromosome translocations in T-PLL frequently involve the
T-cell receptor (TCR) genes, with the TCRα/δ locus on chromo-
some 14q11 affected in 80% of cases.1 In this disorder,
rearrangements of 14q11 usually occur in association with tri-
somy 8q, detected in the CGH analysis of our patient. Both sim-
ilarities and discrepancies were found when conventional and
CGH karyotypes were compared. CGH detected losses on chro-
mosomes 6q and 7q that corresponded with the 6q and 7q dele-
tions found in the G-banded karyotype, respectively. The CGH
loss of 4q, and not of the whole chromosome could be due to
the presence of chromosome 4 material in one of the markers.
In the same way, the gain on 14q11-q32 that was observed in
the CGH profile could reflect the presence of material from 14q
included in the marker chromosome. On the other hand, by CGH
we were able to demonstrate two gains that were not detected
by conventional cytogenetics. A gain of 15q23-26 and, more
significantly, a high level amplification signal on band 8q24, the
chromosomal site of the c-MYC oncogene. Overexpression of
the c-MYC oncogene, as a result of trisomy for 8q has been
reported and could have a role in the pathogenesis of T-PLL,7,8
The usual mechanism for the 8q gain is the i(8)(q10). In our case,
the presence of the 8q24 amplification was only detected by
CGH. The material added to the add(8)(p11), that is duplicated,
might include 8q material. Because of the the poor quality of the
G-banding, it was difficult to identify the material added and
there was no material left for FISH analysis. So far, abnormali-
ties of the 8q24 breakpoint have not been described in T-PLL.
Espinet el al.9 by using cross-species color banding (RxFISH)
detected translocations involving 4q, 8q and 15q in 4 T-PLL
patients with complex karyotypes.9 Deletion of 11p11-12 and
13q13-q34 were only shown in our case after CGH analysis. The
deletion del(13)(q14) has been recently documented by FISH in
a group of patients with T-PLL.10 This abnormality is very com-
mon among B-cell malignancies. Its prognostic impact is vari-
able in the various diseases suggesting different deleted regions
in 13q. At present, there are no data as to whether del(13q) has
a prognostic impact in T-PLL. Monosomies of chromosomes 16
and 20 were only detected by conventional cytogenetics, prob-
ably reflecting the fact that these monosomies were clonal but
not present in all analyzed cells. In conclusion, T-PLL is a rare dis-
order with specific chromosomal-genetic aberrations. The cyto-
genetic abnormalities present in our case are known to be asso-
ciated either specifically with T-cell leukemias, such as
rearrangements of 14q11, or less specifically such as deletions
Figure 1. Metaphase (top) and CGH ideogram showing the
corresponding ratio profiles (bottom) observed in a case of T-
PLL.
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6q, 7q, and 13q. The use of a DNA-based technique such as CGH,
additionally allowed the characterization of otherwise hidden
genetic abnormalities such as the high level amplification on
8q24, the gain on 15q23-26 and the deletion of 11p and 13q. A
more systematic use of CGH in T-PLL may help to estimate the
chromosome changes in this disease more accurately.
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